Patent application number | Description | Published |
20090022334 | Wire-Free Headset, Portable Media Player - There are proposed wireless headphones which have at least one electroacoustic transducer for the reproduction of audio signals, a receiver for receiving wirelessly transmitted audio data, an intermediate memory for putting the received audio data into intermediate storage, an audio decoding unit and a control unit. The audio data wirelessly received by the receiver are firstly buffered or put into intermediate storage in the intermediate memory. The control unit controls reading of the compressed audio data stored in the intermediate memory so that said data are passed to the audio decoding unit where the compressed audio data are decoded and then outputted by means of the electroacoustic transducers. Wireless transmission is effected at a higher speed than the reproduction of the stored audio signals. | 01-22-2009 |
20090103745 | Headset with Active Noise Compensation - There is provided an earphone comprising an electroacoustic reproduction transducer, a microphone ( | 04-23-2009 |
20090136055 | Converter System for an Active Noise Compensation Apparatus - There is provided a transducer system for an active noise compensation apparatus, which has a first end at the ear side and an electroacoustic transducer. The electroacoustic transducer has a diaphragm system and a magnet system, wherein the central region of the diaphragm system is curved towards the magnet system and is in the form of an inverted calotte. A sensor microphone is arranged in a volume between the first end and the region of the curvature of the diaphragm system. | 05-28-2009 |
20100183173 | DYNAMIC SOUND TRANSDUCER AND RECEIVER - There is provided a dynamic sound transducer having a diaphragm system ( | 07-22-2010 |
20110007930 | Receiver - There is provided an earphone having at least one housing ( | 01-13-2011 |
20110031061 | Electroacoustic Transducer - Provided is an electroacoustic transducer having a diaphragm ( | 02-10-2011 |
20110164775 | HEADPHONES AND HEADSET - Headphones comprising a headband ( | 07-07-2011 |
20150030173 | Headphone and Headset - A headphone or earphone is provided which includes a housing with an open end and at least one defined dominant acoustic opening, an acoustically sealing earpad arranged at the open end of the housing, and at least one microphone arranged adjacent to common ear or in the vicinity of the dominant acoustical opening for detecting noise. The dominant acoustic opening is arranged within a radius of 2 cm around a midpoint of the at least one microphone. The headphone or earphone also includes an active-noise-compensation unit for performing an active noise compensation based on the output of the microphone and for generating a compensation signal. The headphone or earphone also includes an electro-acoustical transducer inside the housing for reproducing the compensation signal. | 01-29-2015 |
Patent application number | Description | Published |
20080312278 | Hydroxyquinoline Derivatives - Compounds of the formula I in which X, Y, R | 12-18-2008 |
20090035270 | COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNF alpha - The invention relates to a combination therapy for the treatment of tumors metastases comprising administration of anti-angiogenic agents and rumor necrosis factor alpha (TNFa) optionally together with other cytotoxic agents, such as interferon gamma (IFNy) or chemotherapeutic agents such as anti-EGFR antibodies. The method and the pharmaceutical compositions comprising said agents can result in a synergistic potentiation of the tumor cell proliferation inhibition effect of each individual therapeutic agent, yielding more effective treatment than found by administering an individual component alone. | 02-05-2009 |
20090130098 | Specific therapy using integrin ligands for treating cancer - The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone, concurrently or not in the dosage regime of the present invention. | 05-21-2009 |
20090163556 | GLYCINAMIDE DERIVATIVES AS RAF-KINASE INHBITORS - The present invention relates to glycinamide derivatives of formula I, | 06-25-2009 |
20090253688 | Semicarbazide derivatives as kinase inhibitors - The present invention relates to semicarbazide derivatives of formula I, the use of the compounds of formula I as inhibitors of one or more kinases, the use of the compounds of formula I for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. | 10-08-2009 |
20090298885 | METHYLENE UREA DERIVATIVES - The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. | 12-03-2009 |
20110165150 | Isolated organ perfusion combination therapy of cancer - The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered together with said ligands, such as chemotherapeutic agents and/or radiation therapy, in isolated organ perfusion. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone. | 07-07-2011 |
20110177027 | COMBINATION THERAPY USING ANTI-ANGIOGENIC AGENTS AND TNFalpha - The invention relates to a combination therapy for the treatment of tumors metastases comprising administration of anti-angiogenic agents and tumor necrosis factor alpha (TNFa) optionally together with other cytotoxic agents, such as interferon gamma (IFNy) or chemotherapeutic agents such as anti-EGFR antibodies. The method and the pharmaceutical compositions comprising said agents can result in a synergistic potentiation of the tumor cell proliferation inhibition effect of each individual therapeutic agent, yielding more effective treatment than found by administering an individual component alone. | 07-21-2011 |
20130158076 | Methylene Urea Derivatives - The present invention relates to methylene urea derivatives of formula (I), the use of the compounds of formula (I) as inhibitors of raf-kinase, the use of the compounds of formula (I) for the manufacture of a pharmaceutical composition and a method of treatment, comprising administering said pharmaceutical composition to a patient. | 06-20-2013 |
Patent application number | Description | Published |
20090051215 | METHOD FOR OPERATING A BRAKE SYSTEM FOR MOTOR VEHICLES - The invention relates to a method for operating a braking system for motor vehicles with electrically actuated hydraulic valves, the coils of which are powered up, at least in phases, with currents which modify the currentless state of the hydraulic valves, in order to heat the hydraulic fluid present in the system. The hydraulic fluid is heated via a heating profile which, in accordance with the hydraulic fluid temperature, activates the heating phase of the hydraulic fluid. The heating profile consists of a first heating phase and, subsequent thereto, a second heating phase. During the first heating phase, the coils are powered up in such a way that the coil temperature at the end of the first heating phase corresponds to a pre-defined temperature value of the coil which is at least approximately maintained during the second heating phase when powering up the coils. | 02-26-2009 |
20090055067 | METHOD AND DEVICE FOR CARRYING OUT A STATIONARY HOLDING FUNCTION ON A MOTOR VEHICLE - A method for controlling a valve for maintaining brake pressure in a specified region of a brake circuit in a motor vehicle, in which the valve is controlled using a first control method, the specified region of the brake circuit is monitored with respect to the occurrence of a loss of brake pressure, and in response to a detected loss of brake pressure, the valve is controlled using a second control method. | 02-26-2009 |
20110001351 | Method and Device for the Reproducible Generation of a Specifiable Final Pressure in a Braking System - To achieve a specifiable, and thus reproducible final pressure in at least one part of the brake circuit, the pump is first actuated for pressure buildup or pressure reduction when the valve is closed. When a first specified setpoint pressure is reached, or when a pressure threshold value is exceeded, the valve is put into an open position using a first actuation. After the pump is switched off, the actuation of the valve is modified in such a way that, during a specifiable time, a continuous change of the first actuation is undertaken all the way up to a second actuation, in which the valve assumes a holding position, particularly while taking into consideration the pressure difference which prevails at the valve. | 01-06-2011 |